Changes in trends and pattern of strong opioid prescribing in primary care

European Journal of Pain (United Kingdom)

Volumn 18, Issue 9, 2014, Pages 1343-1351

  Zin, C S ^a,b   Chen, L C ^a   Knaggs, R D ^a,c  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^c QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; FENTANYL; MORPHINE; OXYCODONE; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER PAIN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; UNITED KINGDOM; VERY ELDERLY; ADOLESCENT; CLINICAL PRACTICE; DRUG UTILIZATION; EPIDEMIOLOGY; MIDDLE AGED; PAIN; PRIMARY HEALTH CARE; STATISTICS AND NUMERICAL DATA; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; BUPRENORPHINE; CROSS-SECTIONAL STUDIES; DRUG PRESCRIPTIONS; DRUG UTILIZATION; FEMALE; FENTANYL; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; MORPHINE; OXYCODONE; PAIN; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; YOUNG ADULT;

EID: 84908010796     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2014.496.x     Document Type: Article

References (43)

1. Bekkering, G.E., Soares-Weiser, K., Reid, K., Kessels, A.G., Dahan, A., Treede, R.D., Kleijnen, J., (2011). Can morphine still be considered to be the standard for treating chronic pain? A systematic review including pair-wise and network meta-analyses. Curr Med Res Opin 27, 1477-1491.
2. Boggon, R., van Staa, T.P., Chapman, M., Gallagher, A.M., Hammad, T.A., Richards, M.A., (2013). Cancer recording and mortality in the General Practice Research Database and linked cancer registries. Pharmacoepidemiol Drug Saf 22, 168-175.
3. Bohnert, A.S., Valenstein, M., Bair, M.J., Ganoczy, D., McCarthy, J.F., Ilgen, M.A., Blow, F.C., (2011). Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 305, 1315-1321.
4. Caudill-Slosberg, M.A., Schwartz, L.M., Woloshin, S., (2004). Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 versus 2000. Pain 109, 514-519.
5. Chapman, C.R., Lipschitz, D.L., Angst, M.S., Chou, R., Denisco, R.C., Donaldson, G.W., Fine, P.G., Foley, K.M., Gallagher, R.M., Gilson, A.M., Haddox, J.D., Horn, S.D., Inturrisi, C.E., Jick, S.S., Lipman, A.G., Loeser, J.D., Noble, M., Porter, L., Rowbotham, M.C., Schoelles, K.M., Turk, D.C., Volinn, E., Von Korff, M.R., Webster, L.R., Weisner, C.M., (2010). Opioid pharmacotherapy for chronic non-cancer pain in the United States: A research guideline for developing an evidence-base. J Pain 11, 807-829.
6. Chou, R., Clark, E., Helfand, M., (2003). Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: A systematic review. J Pain Symptom Manage 26, 1026-1048.
7. Chou, R., Ballantyne, J.C., Fanciullo, G.J., Fine, P.G., Miaskowski, C., (2009). Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 10, 147-159.
8. Clausen, T.G., (1997). International opioid consumption. Acta Anaesth Scand 41, 162-165.
9. Dunn, K.M., Saunders, K.W., Rutter, C.M., Banta-Green, C.J., Merrill, J.O., Sullivan, M.D., Weisner, C.M., Silverberg, M.J., Campbell, C.I., Psaty, B.M., Von, K.M., (2010). Opioid prescriptions for chronic pain and overdose: A cohort study. Ann Intern Med 152, 85-92.
10. Fischer, B., Jones, W., Krahn, M., Rehm, J., (2011). Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010. Pharmacoepidemiol Drug Saf 20, 1269-1277.
11. Fredheim, O.M.S., Skurtveit, S., Breivik, H., Borchgrevink, P.C., (2010). Increasing use of opioids from 2004 to 2007: Pharmacoepidemiological data from a complete national prescription database in Norway. Eur J Pain 14, 289-294.
12. Gao, W., Gulliford, M., Higginson, I.J., (2011). Prescription patterns of analgesics in the last 3 months of life: A retrospective analysis of 10-202 lung cancer patients. Br J Cancer 104, 1704-1710.
13. Gilson, A.M., Maurer, M.A., Joranson, D.E., (2007). State medical board members' beliefs about pain, addiction, and diversion and abuse: A changing regulatory environment. J Pain 8, 682-691.
14. Gilson, A.M., Ryan, K.M., Joranson, D.E., Dahl, J.L., (2004). A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage 28, 176-188.
15. Gomes, T., Mamdani, M.M., Dhalla, I.A., Paterson, J.M., Juurlink, D.N., (2011). Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 171, 686-691.
16. Gordon, D.B., Stevenson, K.K., Griffie, J., Muchka, S., Rapp, C., Ford-Roberts, K., (1999). Opioid equianalgesic calculations. J Palliat Med 2, 209-218.
17. Hall, G.C., Carroll, D., Parry, D., McQuay, H.J., (2006). Epidemiology and treatment of neuropathic pain: The UK primary care perspective. Pain 122, 156-162.
18. Hamunen, K., Laitinen-Parkkonen, P., Paakkari, P., Breivik, H., Gordh, T., Jensen, N.H., Kalso, E., (2008). What do different databases tell about the use of opioids in seven European countries in 2002? Eur J Pain 12, 705-715.
19. Hamunen, K., Paakkari, P., Kalso, E., (2009). Trends in opioid consumption in the Nordic countries 2002-2006. Eur J Pain 13, 954-962.
20. Higginson, I.J., Gao, W., (2012). Opioid prescribing for cancer pain during the last 3 months of life: Associated factors and 9-year trends in a nationwide united kingdom cohort study. J Clin Oncol 30, 4373-4379.
21. Hurley, R.W., Adams, M.C.B., (2008). Sex, gender, and pain: An overview of a complex field. Anesth Analg 107, 309-317.
22. Lawrenson, R., Williams, T., Farmer, R., (1999). Clinical information for research; the use of general practice databases. J Public Health 21, 299-304.
23. Leong, M., Murnion, B., Haber, P.S., (2009). Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J 39, 676-681.
24. Mercadante, S., Villari, P., Ferrera, P., Casuccio, A., Mangione, S., Intravaia, G., (2007). Transmucosal fentanyl vs intravenous morphine in doses proportional to basal opioid regimen for episodic-breakthrough pain. Br J Cancer 96, 1828-1833.
25. Noble, M., Treadwell, J.R., Tregear, S.J., Coates, V.H., Wiffen, P.J., Akafomo, C., Schoelles, K.M., (2010). Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev (1), CD006605.
26. Okie, S., (2010). A flood of opioids, a rising tide of deaths. N Engl J Med 363, 1981-1985.
27. Parsells Kelly, J., Cook, S.F., Kaufman, D.W., Anderson, T., Rosenberg, L., Mitchell, A.A., (2008). Prevalence and characteristics of opioid use in the US adult population. Pain 138, 507-513.
28. Ponizovsky, A.M., Pchelintsev, M.V., Marom, E., Zvartau, E.E., (2012). Differences in the consumption rates and regulatory barriers to the accessibility of strong opioid analgesics in Israel and St. Petersburg. Eur J Clin Pharmacol 68, 89-95.
29. Portenoy, R.K., (2004). Appropriate use of opioids for persistent non-cancer pain. Lancet 364, 739-740.
30. Poulsen, K.K., Andersen, S.E., Moreno, S.I., Glintborg, D., Thirstrup, S., Aagaard, L., (2013). General practitioners' and hospital physicians' preference for morphine or oxycodone as first-time choice for a strong opioid: A national register-based study. Basic Clin Pharmacol Toxicol 112, 110-115.
31. Scholten, W., Nygren-Krug, H., Zucker, H.A., (2007). The World Health Organization paves the way for action to free people from the shackles of pain. Anesth Analg 105, 1-4.
32. Sullivan, M., Ferrell, B., (2005). Ethical challenges in the management of chronic nonmalignant pain: Negotiating through the cloud of doubt. J Pain 6, 2-9.
33. Sullivan, M.D., Edlund, M.J., Fan, M.-Y., DeVries, A., Braden, J.B., Martin, B.C., (2008). Trends in use of opioids for non-cancer pain conditions 2000-2005 in Commercial and Medicaid insurance plans: The TROUP study. Pain 138, 440-449.
34. Svendsen, K., Borchgrevink, P.C., Fredheim, O., Hamunen, K., Mellbye, A., Dale, O., (2011). Choosing the unit of measurement counts: The use of oral morphine equivalents in studies of opioid consumption is a useful addition to defined daily doses. Palliati Med 25, 725-732.
35. Trescot, A.M., Glaser, S.E., Hansen, H., Benyamin, R., Patel, S., Manchikanti, L., (2008). Effectiveness of opioids in the treatment of chronic non-cancer pain. Pain Physician 11, S181-S200.
36. Unruh, A.M., (1996). Gender variations in clinical pain experience. Pain 65, 123-167.
37. Walley, T., Mantgani, A., (1997). The UK general practice research database. Lancet 350, 1097-1099.
38. WHO International Working Group for Drug Statistics Methodology. WHO Collaborating Centre for Drug Statistics Methodology. WHO Collaborating Centre for Drug Utilization Research and Clinical Pharmacological Services. Introduction to Drug Utilization Research; 2003.
39. Williams, T., Van Staa, T., Puri, S., Eaton, S., (2012). Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Ther Adv Drug Saf 3, 89-99.
40. Zerzan, J.T., Morden, N.E., Soumerai, S., Ross-Degnan, D., Roughead, E., Zhang, F., Simoni-Wastila, L., Sullivan, S.D., (2006). Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care 44, 1005-1010.
41. National Health Service. National Treatment Agency for Substance Misuse. (2011). Addiction to medicine: An investigation into the configuration and commissioning of treatment services to support those who develop problems with prescription-only or over-the-counter medicine. Retrieved from: http://www.nta.nhs.uk/uploads/addictiontomedicinesmay2011a.pdf (accessed on 25 February 2013).
42. National Health Service. The Information Centre for Health and Social Care. (2013). Prescribing cost analysis England. Retrieved from: http://www.ic.nhs.uk/statistics-and-data-collections/primary-care/prescriptions (accessed on 25 February 2013).
43. WHO Collaborating Centre for Drug Statistics Methodology. (2013). Guidelines for ATC classification and DDD assignment. Retrieved from: http://www.whocc.no/atc-ddd-index/ (accessed on 25 February 2013).